In The Usual Suspects, Verbal Kint explains the final reveal of the film, and I stress the world “film”: “The greatest trick the devil ever pulled was convincing the world he didn’t exist.” I thought about that line while reading the latest from Washington on hemp because the looming federal change to hemp THC
President Trump has announced he will nominate Todd Blanche — his former personal attorney, who has been running the Department of Justice in an acting capacity — to serve as permanent attorney general. I wrote back in April about the personnel shuffle that put Blanche in the acting AG chair and what it might mean
It’s déjà vu all over again. In a move that surprised many — and disappointed more — Virginia Gov. Abigail Spanberger has vetoed legislation that would have finally established a regulated adult-use marijuana retail market in the Commonwealth. The veto is notable not just for what it means for Virginia consumers and operators, but for
Good news for people who don’t want their airline pilots any higher than they already are.
If you’ve been following the rescheduling saga as closely as I have, you might have assumed that once President Trump signed the executive order directing DEA to move state-licensed medical marijuana and DEA-approved medications to Schedule III, the ripple
We are going to white knuckle our way through a blog post about lawyers and guns without doing the obligatory Warren Zevon plug, but we want you to understand how hard this is for us.
Loyal readers of Budding Trends are well aware of marijuana rescheduling, but we offer the following for those who may
In the summer of 2017, Phish lit up Madison Square Garden with a historic 13-night run. Your friends at Budding Trends believe the marijuana rescheduling decision calls for a rollout just as monumental, so we’ve created the Budding Trends Baker’s Dozen as a fitting homage.
Following the federal government’s move to reschedule medical marijuana from
One of the questions I have been asked most often since the Acting Attorney General Todd Blanche signed a final order moving FDA-approved marijuana products and state-licensed medical marijuana from Schedule I to Schedule III of the Controlled Substances Act is whether the federal government’s decision to move state-licensed medical marijuana to Schedule III will
If you’re familiar with operators in the marijuana industry in the United States, you understand that they can be a paranoid bunch — and often with very good reasons. After all, they operated in the grayest areas of the law for years. I can’t help but think of one of the great anthems of the
Dr. Marty Makary resigned as FDA commissioner last week, barely a year after his Senate confirmation. HHS Secretary Robert F. Kennedy Jr. confirmed the departure and indicated the agency is searching for a replacement. Kyle Diamantas, FDA’s deputy commissioner for Food, will serve as acting commissioner in the meantime. The vacancy arrives at an extraordinarily
“What a long, strange trip it’s been.”
When we launched Budding Trends years ago as a modest little blog focused on cannabis law, the idea that we’d one day spend serious time tracking potential widespread access to psychedelics was, to put it mildly, not part of the original pitch deck. And yet, here we are.